Simvastatin Suppresses Lung Inflammatory Response in a Rat Cardiopulmonary Bypass Model

These findings suggest that simvastatin inhibited CPB-induced toll-like receptor 4 upregulation and nuclear factor-κB activation, efficaciously reduing the pulmonary inflammatory response after CPB.